Perioperative therapy with antioxidants and metabolic substrates has the potential to reduce oxidative stress and improve recovery from cardiac surgery, particularly in elderly and high risk cases. The aim of this study was to assess the effect of perioperative metabolic therapy at a biochemical, clinical and economic level in cardiac surgical patients.
Patients (n = 117, mean age 65 ± 1.0 years, 74% male) undergoing elective coronary artery bypass graft (CABG) and/or valve surgery in 2004–2006 were randomised to receive in double blinded fashion, while on the waiting list for surgery (approximately two months) and one month after surgery, either metabolic therapy (coenzyme Q10, magnesium orotate, lipoic acid, omega-3 fatty acids and selenium) or placebo. Biochemical and clinical outcomes were assessed.
Cardiac surgery increased oxidative stress and decreased plasma levels of key antioxidants. Metabolic therapy for a mean of 76 ± 7.5 days increased antioxidant levels preoperatively so that the adverse effect of surgery on redox status was attenuated. Metabolic therapy reduced plasma troponin I, 24 hours postoperatively from 1.5 (1.2–1.8) (geometric mean 95% CI) μg/L, to 2.1 (1.8–2.6) μg/L (P = 0.003) and shortened the mean length of postoperative hospital stay by 1.2 days from 8.1 (7.5–8.7) to 6.9 (6.4–7.4) days (P = 0.004) and reduced hospital costs. Metabolic therapy was inexpensive and had no clinically significant side effects.
Perioperative metabolic therapy for cardiac surgery is safe and inexpensive and is associated with improved redox status, reduced myocardial damage, and shortened length of postoperative hospital stay.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Systemic oxidative stress and its relationship with age and illness. Associazione Medica “Sabin”.J Am Geriatr Soc. 1996; 44: 823-827
- Perioperative risk factors affecting hospital stay and hospital costs in open heart surgery for patients >65 years old.Eur J Cardiothoracic Surg. 1997; : 1133-1140
- Pre-operative preparation for cardiac surgery utilising a combination of metabolic, physical and mental therapy.Heart Lung Circ. 2006; 15: 172-181
- Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.J Thorac Cardiovasc Surg. 2005; 129: 25-32
- The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.J Card Fail. 2006; 12: 464-472
- Coenzyme Q10 in cardiovascular disease.Mitochondrion. 2007; 7: S154-167
- Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.Biochim Biophys Acta. 2009; 1790: 1149-1160
- Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review.Curr Med Chem. 2007; 14: 1539-1549
- Selenium status of the Australian population: effect of age, gender and cardiovascular disease.Biol Trace Elem Res. 2008; 126: S1-S11
- Sensitivity of the recently infarcted heart to cardioplegic arrest. Beneficial effect of pretreatment with orotic acid.J Thorac Cardiovasc Surg. 1989; 97: 593-604
- Magnesium orotate in severe congestive heart failure (MACH).Int J Cardiol. 2009; 131: 293-295
- New evidence for the cardiovascular benefits of long chain omega-3 fatty acids.Curr Atheroscler Rep. 2007; 9: 434-440
- N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.J Am Coll Cardiol. 2005; 45: 1723-1728
- PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH.Am J Physiol. 1999; 276: H149-H158
- Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.Circulation. 2002; 105: 2303-2308
- Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion.Cardiovasc Res. 2007; 73: 710-719
- Oxidative stress injury during cardiac surgery: how important is it?.Cardiovasc Res. 2007; 73: 626-628
- Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis.Eur J Cardiothorac Surg. 2009; 35: 521-527
- Antioxidant therapy is associated with a reduction in the serum levels of mediators of renal injury following lithotripsy for renal calculi.Am J Clin Nutr. 2006; 84: 762-773
- Coenzyme Q10 – its role as a prooxidant in the formation of superoxide anion/hydrogen peroxide and the regulation of the metabolome.Mitochondrion. 2007; 7: S51-61
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.Lancet. 2008; 372: 1223-1230
- Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis.Ann Thorac Surg. 2005; 80: 2402-2406
- Protective role of Coenzyme Q10 in two models of rat lung injury.ANZ J Surg. 2010; 80: 265-270
- Cardiac troponin I concentrations, but not electrocardiographic results, predict an extended hospital stay after coronary artery bypass graft surgery.Clin Chem. 2005; 51: 40-46
Accepted: June 7, 2010
Received: May 14, 2010
© 2010 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.